Published in JAMA on January 26, 2005
Prevalence of kidney stones in the United States. Eur Urol (2012) 9.42
Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol (2010) 3.62
Clinical practice. Calcium kidney stones. N Engl J Med (2010) 3.24
Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials. Arch Intern Med (2010) 2.89
Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) (2009) 2.56
Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol (2014) 2.28
Recent advances in the pathophysiology of nephrolithiasis. Kidney Int (2008) 2.26
Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.22
Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr (2011) 2.21
The association of increasing body mass index and kidney stone disease. J Urol (2009) 1.94
DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol (2009) 1.93
Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant (2011) 1.87
History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol (2010) 1.84
Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol (2012) 1.84
Epidemiology of stone disease. Urol Clin North Am (2007) 1.83
Emergency department visits, use of imaging, and drugs for urolithiasis have increased in the United States. Kidney Int (2013) 1.72
Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant (2012) 1.71
Nephrolithiasis. Prim Care (2008) 1.71
Risk of fracture in urolithiasis: a population-based cohort study using the health improvement network. Clin J Am Soc Nephrol (2014) 1.65
Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol (2014) 1.64
Epidemiology of urolithiasis: an update. Clin Cases Miner Bone Metab (2008) 1.61
Temporal trends in incidence of kidney stones among children: a 25-year population based study. J Urol (2012) 1.59
What is the stone-free rate following flexible ureteroscopy for kidney stones? Nat Rev Urol (2015) 1.55
Body fat content and distribution and urinary risk factors for nephrolithiasis. Clin J Am Soc Nephrol (2013) 1.51
Medical comorbidities associated with pediatric kidney stone disease. Urology (2010) 1.50
An individualized weight-based goal urine volume model significantly improves expected calcium concentrations relative to a 2-L goal urine volume. Urolithiasis (2013) 1.43
Coronary Artery Calcium Score and Association with Recurrent Nephrolithiasis: The Multi-Ethnic Study of Atherosclerosis. J Urol (2015) 1.40
Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis (2014) 1.39
Influence of body size on urinary stone composition in men and women. Urol Res (2006) 1.36
Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol (2011) 1.31
Changes in gender distribution of urinary stone disease. Urology (2009) 1.27
Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans. Hum Mol Genet (2013) 1.23
Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urol (2010) 1.22
Leisure time physical activity, smoking and risk of recent symptomatic urolithiasis: Survey of stone clinic patients. Can Urol Assoc J (2015) 1.21
Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother (2013) 1.14
Dietary and Lifestyle Risk Factors Associated with Incident Kidney Stones in Men and Women. J Urol (2017) 1.14
Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res (2012) 1.14
Metabolic syndrome and urologic diseases. Rev Urol (2010) 1.09
Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women's Health Initiative. J Am Soc Nephrol (2013) 1.09
Effectiveness of Treatment Modalities on Kidney Stone Recurrence. Clin J Am Soc Nephrol (2017) 1.07
Urological aspects of the metabolic syndrome. Nat Rev Urol (2011) 1.06
Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney. Clin J Am Soc Nephrol (2012) 1.06
Profile of the brushite stone former. J Urol (2010) 1.04
Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res (2008) 1.02
New insights into the pathogenesis of renal calculi. Urol Clin North Am (2012) 1.01
Impact of dietary habits on stone incidence. Urol Res (2006) 1.01
Association of body mass index and urine pH in patients with urolithiasis. Urol Res (2009) 0.99
Difference in urinary stone components between obese and non-obese patients. Urol Res (2010) 0.98
The Individualized Target HbA1c: A New Method for Improving Macrovascular Risk and Glycemia Without Hypoglycemia and Weight Gain. Rev Diabet Stud (2009) 0.94
The evolving epidemiology of stone disease. Indian J Urol (2014) 0.93
Association between body mass index and urolithiasis in children. J Urol (2011) 0.92
Epidemiology of stone disease across the world. World J Urol (2017) 0.92
Accuracy of reduced-dose computed tomography for ureteral stones in emergency department patients. Ann Emerg Med (2014) 0.92
Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis. PLoS One (2013) 0.92
Diabetic severity and risk of kidney stone disease. Eur Urol (2013) 0.91
Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis. Mol Cell Proteomics (2011) 0.90
Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis. Urol Res (2011) 0.90
Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. J Transl Med (2012) 0.90
The genetic components of idiopathic nephrolithiasis. Pediatr Nephrol (2010) 0.89
Epidemiological gender-specific aspects in urolithiasis. World J Urol (2013) 0.89
Impact of body mass index on clinical outcomes associated with percutaneous nephrolithotomy. Can Urol Assoc J (2013) 0.89
Physical activity, energy intake and the risk of incident kidney stones. J Urol (2014) 0.88
A genome-wide association study of nephrolithiasis in the Japanese population identifies novel susceptible Loci at 5q35.3, 7p14.3, and 13q14.1. PLoS Genet (2012) 0.88
Dietary therapy for patients with hypocitraturic nephrolithiasis. Nat Rev Urol (2011) 0.88
Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers. Urol Res (2007) 0.88
Frequency of rare allelic variation in candidate genes among individuals with low and high urinary calcium excretion. PLoS One (2013) 0.87
Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease. World J Nephrol (2014) 0.87
The effect of work location on urolithiasis in health care professionals. Urolithiasis (2013) 0.86
Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis? Pediatr Nephrol (2014) 0.86
Metabolic diagnosis in stone formers in relation to body mass index. Urol Res (2011) 0.85
Kidney stone composition in overweight and obese patients: a preliminary report. Res Rep Urol (2013) 0.85
Annual Incidence of Nephrolithiasis among Children and Adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol (2016) 0.85
Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: the ARIC study. Prev Med (2010) 0.85
Severe obesity is associated with 3-fold higher radiation dose rate during ureteroscopy. Urology (2013) 0.85
Serum estradiol and testosterone levels in kidney stones disease with and without calcium oxalate components in naturally postmenopausal women. PLoS One (2013) 0.84
Application of a new method for GWAS in a related case/control sample with known pedigree structure: identification of new loci for nephrolithiasis. PLoS Genet (2011) 0.84
Dietary treatment of nephrolithiasis. Clin Cases Miner Bone Metab (2008) 0.84
Metabolic syndrome and nephrolithiasis: can we hypotize a common background? Clin Cases Miner Bone Metab (2008) 0.84
Relevance of Mediterranean diet and glucose metabolism for nephrolithiasis in obese subjects. J Transl Med (2014) 0.83
Hyperoxaluria after modern bariatric surgery: case series and literature review. Int Urol Nephrol (2009) 0.83
The relationship between insulin, insulin resistance, parathyroid hormone, cortisol, testosterone, and thyroid function tests in the presence of nephrolithiasis: a comprehensive analysis. Cent European J Urol (2014) 0.83
Triglycerides in the human kidney cortex: relationship with body size. PLoS One (2014) 0.83
Ureteroscopy and stones: Current status and future expectations. World J Nephrol (2014) 0.83
Flexible ureterorenoscopy (F-URS) with holmium laser versus extracorporeal shock wave lithotripsy (ESWL) for treatment of renal stone <2 cm: a meta-analysis. Urolithiasis (2015) 0.83
Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden. Pediatr Nephrol (2014) 0.82
Association with meteo-climatological factors and daily emergency visits for renal colic and urinary calculi in Cuneo, Italy. A retrospective observational study, 2007-2010. Int J Biometeorol (2014) 0.82
Epidemiologic insights into pediatric kidney stone disease. Urol Res (2010) 0.82
Demystifying the medical management of nephrolithiasis. Rev Urol (2011) 0.82
Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones. Clin J Am Soc Nephrol (2015) 0.82
Medical expulsive therapy. Indian J Urol (2014) 0.81
Pharmacology of stone disease. Adv Chronic Kidney Dis (2009) 0.81
Preventive fluid and dietary therapy for urolithiasis: An appraisal of strength, controversies and lacunae of current literature. Indian J Urol (2011) 0.81
Biomolecular mechanism of urinary stone formation involving osteopontin. Urol Res (2012) 0.81
The association of prevalent kidney stone disease with mortality in US adults: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Nephrol (2013) 0.81
Preoperative evaluation of pediatric kidney stone prior to percutaneous nephrolithotomy: is computed tomography really necessary? Urolithiasis (2013) 0.81
Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion. Clin J Am Soc Nephrol (2013) 0.81
Protective Effect of Dihydromyricetin Against Lipopolysaccharide-Induced Acute Kidney Injury in a Rat Model. Med Sci Monit (2016) 0.81
Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures. Osteoporos Int (2013) 0.80
Explicit Modeling of Ancestry Improves Polygenic Risk Scores and BLUP Prediction. Genet Epidemiol (2015) 0.80
Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol (2014) 0.80
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med (2008) 12.41
Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69
A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24
Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int (2003) 9.11
Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63
A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care (2003) 7.40
Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19
Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96
Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol (2006) 6.66
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
A prospective study of sleep duration and mortality risk in women. Sleep (2004) 6.11
Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98
Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67
Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60
Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95
Urologic diseases in America project: urolithiasis. J Urol (2005) 4.90
Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72
Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69
Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study. J Clin Oncol (2014) 4.67
Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature (2011) 4.57
Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48
Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46
Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21
Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med (2002) 4.19
Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst (2006) 3.96
Association of nut consumption with total and cause-specific mortality. N Engl J Med (2013) 3.94
Diet and lifestyle risk factors associated with incident hypertension in women. JAMA (2009) 3.94
Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA (2005) 3.88
Estimating the number of deaths due to obesity: can the divergent findings be reconciled? J Womens Health (Larchmt) (2007) 3.86
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation (2005) 3.85
Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. Ann Intern Med (2015) 3.78
Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer (2007) 3.77
Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med (2009) 3.76
Smoking and smoking cessation in relation to mortality in women. JAMA (2008) 3.68
Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA (2002) 3.68
Major dietary protein sources and risk of coronary heart disease in women. Circulation (2010) 3.65
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol (2008) 3.62
Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA (2002) 3.60
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst (2008) 3.55
Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst (2003) 3.54
Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45
Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med (2004) 3.42
Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation (2006) 3.39
A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst (2004) 3.32
Frequency of analgesic use and risk of hypertension among men. Arch Intern Med (2007) 3.29
History of kidney stones and the risk of coronary heart disease. JAMA (2013) 3.23
Diabetes mellitus and the risk of nephrolithiasis. Kidney Int (2005) 3.17
Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 3.11
A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08
Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care (2006) 3.06
Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst (2002) 3.03
Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr (2002) 3.00
Current issues in measurement and reporting of urinary albumin excretion. Clin Chem (2008) 2.98
Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci (2008) 2.98
Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol (2008) 2.96
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol (2009) 2.94
Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc (2005) 2.86
Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology (2002) 2.86
Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst (2011) 2.85
Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med (2011) 2.85
Prevalence and characteristics of tinnitus among US adults. Am J Med (2010) 2.84
Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension (2008) 2.81
Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation (2002) 2.78
Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) (2006) 2.77
A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov (2011) 2.77
Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol (2002) 2.75
Mercury and the risk of coronary heart disease in men. N Engl J Med (2002) 2.71
Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am J Epidemiol (2005) 2.70
A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med (2005) 2.66
Smoking and prostate cancer survival and recurrence. JAMA (2011) 2.63
Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol (2004) 2.60
Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med (2004) 2.56
Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res (2009) 2.54
Long-term aspirin use and mortality in women. Arch Intern Med (2007) 2.54
Prospective study of major dietary patterns and stroke risk in women. Stroke (2004) 2.52
Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51
Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst (2009) 2.50
A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst (2002) 2.49
Physical activity and risk of coronary heart disease in India. Int J Epidemiol (2004) 2.48
Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet (2008) 2.45
Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum (2007) 2.44
Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol (2011) 2.42
Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab (2002) 2.40
Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation (2006) 2.35